168
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Safety and toxicological evaluation of Aflapin®: A novel Boswellia-derived anti-inflammatory product

, , , , , & show all
Pages 556-563 | Received 13 Apr 2010, Accepted 15 May 2010, Published online: 29 Sep 2010

References

  • Aman U, Balu G. 2009. Pharmacological activities of Boswellia serrata roxb. Mini review. Ethnobotanical Leaflets 13:766–774.
  • Ammon HPT. 2008. Medical use of incense (Olibanum) in different historical periods. Phytomedicine 15:541–546.
  • Dev S. 1999. Ancient-modern concordance in ayurvedic plants: some examples. Environ Health Perspect 107:783–789.
  • Draize JH. 1965. The appraisal of the safety of chemicals in foods, drugs and cosmetics. Dermal Toxicity. Topeka, KS: Association of Food and Drug Officials of the US. pp 46–59.
  • Draize JH, Woodward G, Calvary HO. 1944. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther 82:377–390.
  • Ethan B, Heather B, Theresa DH, Ivo F, Sadaf H, Jens H, David S, Catherine U. 2004. Boswellia: an evidence- based systematic review by the natural standard research collaboration. J Herbal Pharmacother 4:63–83.
  • Gupta I, Gupta V, Parihar A, Gupta S, Ludtke R, Safayhi H, Ammon HP. 1998. Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study. Eur J Med Res 3:511–514.
  • Kay JH, Calandra JC. 1962. Interpretation of eye irritation tests. J Soc Cos Chem 13:281–289.
  • Krishnaraju AV, Sundararaju D, Sengupta K, Venkateswarlu S, Trimurtulu G. 2009. Safety and toxicological evaluation of demethylatedcurcuminoids a novel standardized curcumin product. Toxicol Mech Methods 19:447–460.
  • Krishnaraju AV, Sundararaju D, Srinivas P, Sengupta K, Rao CV, Trimurtulu G. 2010. Safety and toxicological evaluation of a novel anti-obesity formulation LI85008F in animals. Toxicol Mech Methods 20:59–68.
  • Lalithakumari K, Krishnaraju AV, Sengupta K, Subbaraju GV, Chatterjee A. 2006. Safety and toxicological evaluation of 3-acetyl-11ketoβ boswellicacid (AKBA)-Enriched Boswellia serrata Extract (5-Loxin®). Toxicol Mech Methods 16:1–28.
  • Office of Prevention, Pesticides and Toxic Substances (OPPTS) 870.2500. 1998. Available online at: http://iccvam.niehs.nih.gov/SuppDocs/FedDocs/EPA/EPA_870_2500.pdf. Accessed 23.April 2010.
  • Sastri BN. 1962. The Wealth of India-Raw materials VI. New Delhi, India: CSIR. pp 425–429.
  • Sengupta K, Krishnaraju AV, Satish AR, Mishra S, Trimurtulu G, Sarma KVS, Dey D, Raychaudhuri SP. 2008. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin® for treatment of osteoarthritis of the knee. Arthritis Res Ther 10:R85.
  • Sharma R, Singh S, Singh GD, Khajuria A, Sidiq T, Singh SK, Chashoo G, Pagoch SS, Kaul A, Saxena AK, Johri RK, Taneja SC. 2009. In vivo genotoxicity evaluation of a plant based antiarthritic and anticancer therapeutic agent Boswelic acids in rodents. Phytomedicine 16:1112–1118.
  • Singh GB, Atal CK. 1986. Pharmacology of extracts of salai guggal ex-Boswellia serrata, a new non-steroidal anti-inflammatory agent. Agents Actions 18:407–412.
  • Sontakke S, Thawani V, Pimpalkhute S, Kabra P, Babhulkar S, Hingorani L. 2007. Open, randomized, controlled clinical trial of Boswellia serrata extract as compared to valdecoxib in osteoarthritis of knee. Indian J Pharmacol 39:27–29.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.